← Browse by Condition
Medical Condition

smoking

Total Trials
12
Recruiting Now
12
Trial Phases
Phase 2, Phase 4, Phase 3

ClinicalMetric tracks all active clinical trials for smoking sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — smoking Clinical Trials

How many clinical trials are currently recruiting for smoking?
ClinicalMetric currently tracks 12 actively recruiting clinical trials for smoking, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for smoking?
smoking research spans Phase 2 (1 trial), Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a smoking clinical trial?
Eligibility criteria for smoking trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Phase 4
1
Top Sponsors
RAI Services Company 2 trials
University of California, San Francisco 1 trial
University of Florida 1 trial
Children's Hospital of Philadelphia 1 trial
Hospital St. Joseph, Marseille, France 1 trial

Recruiting Clinical Trials

NCT04722835
Recruiting
Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
Enrollment
40 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT07132814
Recruiting
Abuse Liability for Five Modern Oral Nicotine Products
Enrollment
40 pts
Location
United States
Sponsor
RAI Services Company
View Trial →
NCT05814055 Phase 2
Recruiting
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
Enrollment
76 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT07598136
Recruiting
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Enrollment
1,280 pts
Location
United States
Sponsor
RAI Services Company
View Trial →
NCT06582693
Recruiting
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
Enrollment
3,200 pts
Location
United States
Sponsor
Children's Hospital of Philade...
View Trial →
NCT05486455
Recruiting
Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
Enrollment
1,000 pts
Location
France
Sponsor
Hospital St. Joseph, Marseille...
View Trial →
NCT07089901 Phase 4
Recruiting
Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment
Enrollment
600 pts
Location
United States
Sponsor
Duke University
View Trial →
NCT06561971
Recruiting
Effect of Different Centrifuge Values on Saliva High Sensitive C-Reactive Protein (Hs-CRP) Levels in Individuals With Different Smoking Amounts
Enrollment
90 pts
Location
Turkey (Türkiye)
Sponsor
Izmir Katip Celebi University
View Trial →
NCT05557487
Recruiting
Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion Administration
Enrollment
6,618 pts
Location
Taiwan
Sponsor
Gee-Chen Chang
View Trial →
NCT06535867
Recruiting
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
Enrollment
5,122 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT07312552
Recruiting
Association of Periodontal Status and Smoking With Salivary Inflammasome Markers
Enrollment
116 pts
Location
Turkey (Türkiye)
Sponsor
Uskudar University
View Trial →
NCT05154669 Phase 3
Recruiting
Integrating Financial Coaching and Smoking Cessation Coaching
Enrollment
602 pts
Location
United States
Sponsor
NYU Langone Health
View Trial →

Related Conditions

tobacco use (3) tobacco smoking (2) copd (1) smoking behaviors (1) tobacco (1) smoking cessation (1) second hand tobacco smoke (1) lung cancer (1) high risk cancer (1) pollution exposure (1) family relations (1) smoking cigarette (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology